Revelation Biosciences, Inc.

REVB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jan 12, 2022 CURRENT REPORT
4 Jan 11, 2022 FORM 4 FILING
SC 13G/A Jan 11, 2022 SCHEDULE 13G/A
8-K Dec 23, 2021 CURRENT REPORT
DEFA14A Dec 17, 2021 CURRENT REPORT
8-K Dec 17, 2021 CURRENT REPORT
424B3 Dec 16, 2021 PROSPECTUS
EFFECT Dec 14, 2021
CORRESP Dec 14, 2021
S-4/A Dec 13, 2021 REGISTRATION STATEMENT
S-4/A Dec 7, 2021 REGISTRATION STATEMENT
CORRESP Dec 6, 2021
UPLOAD Nov 26, 2021
DEFA14A Nov 24, 2021 CURRENT REPORT
8-K Nov 24, 2021 CURRENT REPORT
CORRESP Nov 4, 2021
S-4/A Nov 4, 2021 REGISTRATION STATEENT
3 Nov 2, 2021 FORM 3 FILING
425 Nov 1, 2021 FORM 425
10-Q Oct 29, 2021 QUARTERLY REPORT
UPLOAD Oct 25, 2021
425 Oct 25, 2021 425
8-K Oct 19, 2021 CURRENT REPORT
8-K Oct 13, 2021 CURRENT REPORT
SC 13G/A Oct 12, 2021
← Newer Page 13 of 16 · 387 filings Older →